Approvals/CIMA-AEMPS/CABAZITAXEL MYLAN 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

CABAZITAXEL MYLAN 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG

Mylan Pharmaceuticals S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 01c50bc9daa5c466
Drug Cima Aemps Name: CABAZITAXEL MYLAN 60 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG
Register Number: 85660
Holder Company Name: Mylan Pharmaceuticals S.L.
Marketing Company Name: Mylan Pharmaceuticals S.L.
Authorization Date: 2021-02-12
Dosage Form: CONCENTRADO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 60 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Mylan Pharmaceuticals S.L.

CABAZITAXEL

60 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 12, 2021

Approval ID

01c50bc9daa5c466

Type

Standard